Kim E D, Onel E, Honig S C, Lipschultz L I
Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA.
Int Urol Nephrol. 1997;29(6):647-52. doi: 10.1007/BF02552181.
To determine the prevalence of cystic lesions of the prostate involving the ejaculatory ducts using transrectal ultrasound (TRUS).
The prevalence of cystic lesions of the prostate involving the ejaculatory ducts was determined in a prostate cancer screening group and also in an "at risk" population of men with infertility.
Cystic lesions of the prostate involving the ejaculatory ducts as detected by TRUS were detected in 5.0% (20 of 400 consecutive men) in a prostate cancer screening population. In contrast, these abnormalities were present in 17.0% (23/135) of the "at risk" infertile men who had TRUS performed.
This is the largest series to date defining the prevalence of TRUS-identified cystic lesions of the prostate in a non-infertility population. While cystic lesions of the prostate involving the ejaculatory duct are uncommon in an otherwise healthy and fertile male, their prevalence increases in infertile men whose examination and semen analyses make them "at risk" for having ductal obstruction.
使用经直肠超声(TRUS)确定累及射精管的前列腺囊性病变的患病率。
在前列腺癌筛查组以及不育“高危”男性人群中确定累及射精管的前列腺囊性病变的患病率。
在前列腺癌筛查人群中,经TRUS检测发现累及射精管的前列腺囊性病变在400名连续男性中有5.0%(20例)。相比之下,在接受TRUS检查的不育“高危”男性中,这些异常情况存在于17.0%(23/135)的患者中。
这是迄今为止在非不育人群中确定经TRUS识别的前列腺囊性病变患病率的最大系列研究。虽然累及射精管的前列腺囊性病变在其他方面健康且有生育能力的男性中并不常见,但在那些检查和精液分析显示有导管阻塞“风险”的不育男性中,其患病率会增加。